At a Glance
| Peganum harmala | 25B-NBOMe | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Routes | insufflatedsublingual | |
| Effects | 10 documented | 42 documented |
| Interaction | Caution | |
Peganum harmala, a Psychedelic, and 25B-NBOMe, a Psychedelic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Psychedelics, meaning they share a common pharmacological foundation. They share 6 documented effects in common, with 4 effects unique to Peganum harmala and 36 unique to 25B-NBOMe. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Peganum harmala | 25B-NBOMe | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Routes | insufflatedsublingual | |
| Effects | 10 documented | 42 documented |
| Interaction | Caution | |
| Level | Dose |
|---|---|
| Threshold | 25 µg |
| Light | 50–200 µg |
| Common | 200–350 µg |
| Strong | 350–500 µg |
| Level | Dose |
|---|---|
| Threshold | 50 µg |
| Light | 100–300 µg |
| Common | 300–500 µg |
| Strong | 500–700 µg |
MAOIs dramatically potentiate psychedelics; drastically reduce dose and exercise extreme caution
No dangerous interactions recorded.